Review: Utilization of Decision Support System in Identification of Drug-related Problems in Geriatric Patients
DOI:
https://doi.org/10.12928/dpphj.v19i1.11908Keywords:
Decision support system, Drug-related problems, GeriatricAbstract
Background: Globally, there were 703 million people aged 65 years or older in 2019. The largest population were in East and Southeast Asia (260 million) followed by Europe and North America (more than 200 million). This number is expected to grow to over 1.5 billion people by 2050. Treatment-related problems are events associated with drug use that may affect the patient's therapeutic goals. The prevalence of treatment-related problems is estimated to be 45.1% in populations meeting criteria for advanced age, polypharmacy, and multimorbidity. A decision support system (DSS) is developed based on individual conditions to provide recommendations for therapeutic and dosage selection, and to prevent drug interactions in complex cases. This study aims to evaluate the use of DSS in identifying treatment-related problems in geriatric patients across various countries. Method: This study uses a narrative review method to systematically discuss previous research findings. Results: This review examined journals on the use of decision support systems in identifying drug-related problems in geriatric patients. A search article published between 2016-2021 in the PubMed database yielded 10 relevant articles. DSS tools have shown to improve the continuity of care for geriatric patients. Previous DSS tools used include AGAlink, G-MEDSS, PRIMA-eDS, STRIPA, SENATOR, and TRIM. Conclusion: DSS represents a significant technological advancement that can be applied to prevent and reduce inaccuracies in prescribing, particularly for geriatric patients.
References
United Nations. World Population Ageing. New York: 2019.
Badan Pusat Statistik (BPS). Statistik Penduduk Lanjut Usia. Jakarta: 2019.
He Z, Bian J, Carretta HJ, Lee J, Hogan WR, Shenkman E, et al. Prevalence of multiple chronic conditions among older adults in Florida and the United States: Comparative analysis of the OneFlorida data trust and national inpatient sample. J Med Internet Res. 2018; 20(4):e137. https://doi.org/10.2196/jmir.8961.
Pfister B, Jonsson J, Gustafsson M. Drug-related problems and medication reviews among old people with dementia. BMC Pharmacol Toxicol. 2017; 18(52). https://doi.org/10.1186/S40360-017-0157-2.
Hayes TL, Larimer N, Adami A, Kaye JA. Medication Adherence in Healthy Elders. J Aging Health. 2009; 21(4):567–580. https://doi.org/10.1177/0898264309332836.
Bekele F, Tsegaye T, Negash E, Fekadu G. Magnitude and Determinants of Drug Related Problems among Patients Admitted to Medical wards of Southwestern Ethiopian Hospitals: A Multicenter Prospective Observational Study. PLoS One. 2021; 16(3):e0248575. https://doi.org/10.1371/journal.pone.0248575.
Garin N, Sole N, Lucas B, Matas L, Moras D, Rodrigo-Troyano A, et al. Drug Related Problems in Clinical Practice: a cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions. Sci Rep. 2021; 11:883. https://doi.org/10.1038/s41598-020-80560-2
Sell R, Schaefer M. Prevalence and Risk Factors of Drug-Related Problems Identified in Pharmacy-Based Medication Reviews. Int J Clin Pharm. 2019; 42(2):588-597. https://doi.org/10.1007/s11096-020-00976-8.
Chang C-T, Ang J-Y, Islam MA, Chan H-K, Cheah W-K, Gan SH. Prevalence of Drug-Related Problems and Complementary and Alternative Medicine Use in Malaysia: A Systematic Reviewand Meta-Analysis of 37,249 Older Adults. Pharmaceutical. 2021; 14(3):187. https://doi.org/10.3390/ph14030187.
Arini YD, Rahmawati F, Andayani TM. The Risk Factors Of Drug Related Problems Events In Chronic Disease Outpatients At Internal Clinic. J Manaj Dan Pelayanan Farm. 2016; 6(2):83-94.
Saldanha V, Araujo IB de, Lima SLVC, Martins RR, Antonio Gouveia Oliveira. Risk Factors for Drug-related Problems in A General Hospital: A large prospective cohort. PLoS One. 2020; 15(5):e0230215. https://doi.org/10.1371/journal.pone.0230215.
Robertson LA, Mclean M-A, Sardar CM, Bryson G, Kurdi A. Evaluation of the prescribing decision support system Synonyms in a primary care setting: a mixed-method study. Int J Pharm Pract. 2020; 28(5):473–482. https://doi.org/10.1111/ijpp.12629.
Chin DL, Wilson MH, Trask AS, Johnson VT, Neaves BI, Gojova A, et al. Repurposing clinical decision support system data to measure dosing errors and clinician-level quality of care. J Med Syst. 2020; 44:185. https://doi.org/10.1007/s10916-020-01603-9.
Yourman L, Concato J, Agostini J V. Use of Computer Decision Support Interventions to Improve Medication Prescribing in Older Adults: a systematic review. Am J Geriatr Pharmacother. 2008; 6(2):119–129. https://doi.org/10.1016/j.amjopharm.2008.06.001.
Marasinghe KM. Computerised Clinical Decision Support Systems to Improve Medication Safety in Long-term Care Homes: a systematic review. BMJ Open. 2015: 5. https://doi.org/10.1136/bmjopen-2014-006539.
Damoiseaux-Volman BiA, Vekde N van der, Medlock S. Effect of Interventions With a Clinical Decision Support System for Hospitalized Older Patients: Systematic Review Mapping Implementation and Design Factors. JMIR Med Informatics. 2021; 9(7). https://doi.org/10.2196/28023.
O’Donnell LK, Sawan M, Reeve E, Gnjidic D, Chen TF, Kelly PJ, et al. Implementation of the goal-directed medication review electronic decision support system (G-MEDSS)© into home medicines review: a protocol for a clusterrandomised clinical trial in older adults. BMC Geriatr. 2020; 20:378. https://doi.org/10.1186/s12877-020-01681-x.
Rieckert A, Reeves D, Altiner A, Drewelow E, Esmail A, Flamm M, et al. Use of an Electronic Decision Support Tool to Reduce Polypharmacy in Elderly People with Chronic Disease: Cluster Randomised Controlled Trial. BMJ Open. 2020; 369:m1822. https://doi.org/10.1136/bmj.m1822.
Sonnichsen A, Trampisch US, Rieckert A, Piccoliori G, Vogele A, Flamm M, et al. Polypharmacy in chronic disease-Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support (PRIMA-eDS): study protocol for a randomized controlled trial. Biomed Cent. 2016; 17:57. https://doi.org/10.1186/s13063-016-1177-8.
Adam L, Moutzouri E, Baumgartner C, Loewe AL, Feller M, M'Rabbet-Bensalah K, et al. Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): a cluster randomised controlled trial. BMJ Open. 2019; 9(6):e026769. https://doi.org/10.1136/bmjopen-2018-026769.
Boersma MN, Huibers CJA, Drenth-van Maanen AC, Emmelot-Vonk MH, Wilting I, Knol W. The effect of providing prescribing recommendations on appropriate prescribing: A cluster-randomized controlled trial in older adults in a preoperative setting. Br J Clin Pharmacol. 2019; 85(9):1974–1983. https://doi.org/10.1111/bcp.13987.
Lavan AH, O’Mahony D, Gallagher P, Fordham R, Flanagan E, Dahly D, et al. The effect of SENATOR (Software ENgine for the Assessment and optimisation of drug and non-drug Therapy in Older peRsons) on incident adverse drug reactions (ADRs) in an older hospital cohort - Trial Protocol. BMC Geriatr. 2019; 19:40. https://doi.org/10.1186/s12877-019-1047-9.
Vélez-Díaz-Pallarés M, Álvarez Díaz AM, Gramage Caro T, Vicente Oliveros N, Delgado-Silveira E, Muñoz García M, et al. Technology-induced errors associated with computerized provider order entry software for older patients. Int J Clin Pharm. 2017; 39:729–742. https://doi.org/10.1007/s11096-017-0474-y.
Jungo KT, Rozsnyai Z, Mantelli S, Floriani C, Lowe AL, Kindemann F, et al. ‘Optimising PharmacoTherapy In the multimorbid elderly in primary CAre’ (OPTICA) to improve medication appropriateness: study protocol of a cluster randomised controlled trial. BMJ Open. 2019; 9(9):e031080. https://doi.org/10.1136/bmjopen-2019-031080.
Fried TR, Niehoff KM, Street RL, Charpentier PA, Rajeevan N, Miller PL, et al. Effect of the Tool to Reduce Inappropriate Medications (TRIM) on Medication Communication and Deprescribing. J Am Geriatr Soc. 2018; 65(10):2265-2271. https://doi.org/10.1111/jgs.15042.
O’Mahony D. STOPP/START Criteria for Potentially Inappropriate Medications/Potential Prescribing Omissions in Older People: origin and progress. Expert Rev Clin Pharmacol. 2020; 13(1): 15–22. https://doi.org/10.1080/17512433.2020.1697676.
Radiyanti, Fita R, Probosuseno. Peresepan Obat Tidak Tepat dan Adverse Drug Events pada Pasien Geriatri Rawat Inap di Rumah Sakit Umum. J Manaj Dan Pelayanan Farm. 2016; 6(1):47–54. https://doi.org/10.22146/jmpf.238.
Moon JD, Galea MP. Overview of clinical decision support systems in healthcare. Med. Imaging Concepts, Methodol. Tools, Appl., 2016, p. 1501–1527.
Poomari Durga K, Abirami MS. AI Clinical Decision Support System (AI-CDSS) for Cardiovascular Diseases. 2023 Int Conf Comput Sci Emerg Technol CSET 2023. 2023; :1–7. https://doi.org/10.1109/CSET58993.2023.10346885.
Yaghoubi Ashrafi M, Karami M, Safdari R, Nazeri A. Selective overview on decision support systems: Focus on HealthCare. Life Sci J. 2013; 10(4):920–928.
Aiello F, Teijon-Lumbreras, Gallardo-Pizarro, Garcia-Vidal. Strengths and weaknesses of computerized clinical decision support systems: insights from a digital control center (C3 COVID-19) for early and personalized treatment for COVID-19. Rev Esp Quimioter. 2025; 38(1):1-7. https://doi.org/10.37201/req/088.2024.
Avalos-Mejia AM, García-Cruz JC, Escobedo de la Peña J, Garrido-Acosta O, Juárez-Cedillo T. Reduction of inappropriate prescriptions in older adults through the support of Asynchronous Geriatric Counseling Online (AGAlink): Implemented in primary care. PLoS One. 2021; 16(11):e0258414. https://doi.org/10.1371/journal.pone.0258414.
Nguyen T, Wong E, Ciummo F. Polypharmacy in Older Adults: Practical Applications Alongside a Patient Case. J Nurse Pract. 2020; 16(3):205-209. https://doi.org/10.1016/j.nurpra.2019.11.017.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Universitas Ahmad Dahlan
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors transfer the copyright and grant the Disease Prevention and Public Health Journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material) the work for any purpose, even commercially with an acknowledgement of the work's authorship and initial publication in Disease Prevention and Public Health Journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in Disease Prevention and Public Health Journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
